Zhejiang Huahai Pharmaceutical Co Ltd

600521

Company Profile

  • Business description

    Zhejiang Huahai Pharmaceutical Co Ltd is engaged in research and development, production, and sales of multi-dosage preparations, biological drugs, innovative drugs, and specialty APIs. The company’s products include irbesartan hydrochlorothiazide tablets, losartan potassium tablets, paroxetine hydrochloride tablets, sertraline hydrochloride tablets, linagliptin tablets, dabigatran etexilate capsules, pemetrexed disodium for injection, esomeprazole magnesium enteric-coated capsules, torsemide injection, and others.

  • Contact

    Xunqiao
    Zhejiang Province
    Linhai317024
    CHN

    T: +86 57685010288

    https://www.huahaipharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    9,065

Stocks News & Analysis

stocks

Alibaba fair value increases by 49%

Stronger-than-expected AI demand internationally and domestically.
stocks

Our fair value on ASX share falls by half

Downgrading our estimates due to lower growth.
stocks

A 5-Star US stock to buy with a near-5% yield

Undervalued by 23%, this cheap dividend stock is a top pick in its sector.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,148.5045.400.50%
CAC 407,880.8710.190.13%
DAX 4023,745.065.590.02%
Dow JONES (US)46,316.0768.780.15%
FTSE 1009,299.8415.010.16%
HKSE26,622.88494.681.89%
NASDAQ22,591.15107.090.48%
Nikkei 22545,043.75311.24-0.69%
NZX 50 Index13,142.539.970.08%
S&P 5006,661.2117.510.26%
S&P/ASX 2008,862.8052.100.59%
SSE Composite Index3,862.5334.430.90%

Market Movers